Evidence map›Paper›PMID 33400182›Full record

ArticleNeurotoxicity research2021

Protective Effect of Vitamin D3 Against Pb-Induced Neurotoxicity by Regulating the Nrf2 and NF-κB Pathways.

Hosein Hoseinrad, Jahan Keivanlou Shahrestanaki, Mehrdad Moosazadeh Moghaddam, Amirreza Mousazadeh, Pouya Yadegari, Nousha Afsharzadeh

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Role of vitamin DToxicology research · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Se Alleviated Pb-Caused Neurotoxicity in Chickens:Antioxidants (Basel, Switzerland) · 2024
    Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Hosein HoseinradDepartment of Cell Biology and Anatomical Science, Faculty of Medicine, Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Jahan Keivanlou ShahrestanakiStudent Research Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Mehrdad Moosazadeh MoghaddamApplied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. rsr.moosazadeh@bmsu.ac.ir.
Amirreza MousazadehFaculty of Chemistry, Shahrood University of Technology, Shahrood, Iran.
Pouya YadegariStudent Research Committee, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nousha AfsharzadehAzad Islamic University, Damghan Branch, Damghan, Iran.
Shahid Beheshti University of Medical Sciences · IRBaqiyatallah University of Medical Sciences · IRIslamic Azad University, Damghan Branch · IRSabzevar University of Medical Sciences · IRUniversity of Shahrood · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lead (Pb) is a known toxic heavy metal which accumulates in different tissues and causes oxidative stress (OS) and inflammation. The brain tissue is considered as one of the most vulnerable organs to the Pb-induced toxicity. The aim of this study was to investigate the therapeutic effects of vitamin D3 (VD) supplementation against the damages caused by chronic Pb toxicity in the cerebral cortex. Forty Wistar rats were divided into four equal groups and were treated as follows: control group received no treatment, VD group received 1000 IU/kg of VD by intramuscular injection every other day, Pb group received 1000 mg/L of Pb in drinking water, and Pb + VD group received VD and Pb simultaneously. The experiment lasted for 4 weeks and the analyses were conducted 24 h after the last administrations. The obtained results demonstrated that Pb significantly increased cortical lipid peroxidation and reactive oxygen species (ROS) levels. At the same time, there was a significant reduction in glutathione (GSH) content, catalase (CAT), and superoxide dismutase (SOD) activities, as well as a significant increase in the tissue level of inflammatory cytokines. Furthermore, Pb increased the messenger RNA (mRNA) expression level of nuclear factor erythroid 2-related factor 2 (Nrf2) and nuclear factor-kappa B (NF-κB). Anyhow, VD administration during the period of Pb exposure suppressed the OS and inflammation by increasing the antioxidant molecules and decreasing the inflammatory cytokines and consequently repaired Pb-induced cortical tissue damages. Remarkably, these responses were concomitant with the alterations in Nrf2 and NF-κB gene expressions. In conclusion, the present study discloses the potential protective effects for VD against Pb-induced neurotoxicity via anti-inflammatory and antioxidative mechanisms.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsCerebral CortexCholecalciferolLeadLipid PeroxidationMaleNF-E2-Related Factor 2NF-kappa BOxidative StressRatsRats, WistarReactive Oxygen SpeciesSignal TransductionAnti-Inflammatory AgentsAntioxidantsCholecalciferolLeadNfe2l2 protein, ratNF-E2-Related Factor 2NF-kappa BReactive Oxygen SpeciesBrainInflammationLeadNF-κbNrf2Oxidative stressVitamin D

Identifiers

PMID33400182
OpenAlexW3118748057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.